Devicare and Premier Medical Ltd organised a workshop dedicated to providing an overview of the latest advances in the treatment and clinical handling of lithiasis or kidney stones, on 7 October in Dublin, which was attended by prestigious urologists and Irish health care professionals. The presentation was led by Vera Griffin, Managing Director of Premier Medical Ltd.
Devicare has obtained the patent in Europe and the United States for its electrochemical ion sensor, which is integral to the Lit-Control® pH Meter product for frequent urinary conditions, thus making progress in its intellectual and industrial protection strategy and gaining access to key markets in medical and health technologies.
Improving your urinary health is now easier thanks to the new website Lit-control.es. The e-commerce site, designed by Devicare’s digital marketing department, is completely patient-focused: detailed information on Lit-Control® products to monitor urinary pH levels, online purchases and a private area with different functionalities that provide improved know-how and patient empowerment in the management of their health (a record of readings and medical history, order tracking, offers and exclusive discounts...).
Devicare is moving forward in its international expansion by closing licensing and distribution agreements in Argentina, Uruguay and Peru. Various pharmaceutical companies will introduce the products from the Lit-Control® brand to improve the urinary healthcare of the residents of Latin America. The company had previously announced its entry into Mexico and Colombia.
Devicare and nine leading hospitals in urology have started the pioneering international "Double J" study to evaluate the combined use of a medical device and a nutraceutical in controlling urinary pH and inhibiting crystallisation in order to prevent the calcification of double J stent catheters and reduce the number of associated complications.
The prestigious urologists Manoj Monga of the Cleveland Clinic and Olivier Traxer of the Sorbonne and Pierre and Marie Curie University are organising the first The Talents (The Trans-Atlantic Leaders in Endourological Technologies) symposium, from 5 to 7 April in Paris, in order to build bridges between young European and North American leaders in the field of endourology.
The 33rd European Urology Congress (EAU 2018) closed its doors yesterday in Copenhagen with excellent figures: 15,000 urologists, 160 companies and 2,000 business representatives. Devicare has been present in the exhibition area together with one of its international partners presenting Lit-Control®, the first medical solution which allows recurrent urinary diseases to be effectively addressed with an innovative solution enabling patients to check their own urinary pH with remote monitoring.
Devicare has obtained the patent in Spain for a new electrochemical ion sensor, which is the most advanced of its type on the market, improving the features of the Lit-Control pH Meter® medical device for self-monitoring chronic urological diseases (lithiasis, infections, overactive bladder, calcification of urinary catheters, etc.). Specifically, the sensor incorporates a reference electrode that prevents it from drying after its use.
Devicare has obtained the patent in Spain for a new electrochemical ion sensor, which is the most advanced of its type on the market, improving the features of the Lit-Control pH Meter® medical device for self-monitoring chronic urological diseases (lithiasis, infections, overactive bladder, calcification of urinary catheters, etc.). Specifically, the sensor incorporates a reference electrode that prevents it from drying after its use.
LELR-AEU 2018 Meeting report Advances in the treatment and medical management of lithiasis, which affects 15% of Spain’s population and is increasing considerably, namely renal lithiasis, were the focus of the 28th National Meeting of the Groups of Lithiasis, Endourology, Laparoscopy and Robotics organized by the Spanish Association of Urology on January 25 and 26 in Cordoba.
Board Member and Private Investor in different biotech start-ups.
Former President of Medical Devices Committee at Catalonia Association of Biotech Companies.
Master in Business Administration.
Master in International Business.
Master in Entrepreneurship & Innovation.
BSc. Industrial Engineering.
BSc. Electronic Engineering.
+10 years of experience in Business Development in MD companies.
QMS Manager at Mesoestetic.
Deputy Quality Manager at SANJO.
PDD at IESE.
Master in Business Administration.
BSc in Chemical Engineering.
+15 years of experience managing QA and QC in different industrial companies (pharma and automotive sectors)
Marketing Director at Rubió.
Marketing Director at Lacer.
Master in Business Administration.
BSc in Law.
+25 years in strategic marketing positions managing budgets +€20 M, sales force +300 representatives, and having launched +10 products to the market in Urology and Cardiology.
+15 Years of experience in strategic positions regarding prototype and production in prestigious companies as Sanyo or Ateknea. Master’s in production management. BSc Electronic Engineering.
Scientific Director at AB-Biotics
PhD in Microbiology
BSc in Food Science and Technology
BSc in Biology
+15 years of experience in strategic research positions managing the development of innovative nutraceuticals and monitoring clinical trials
System Manager at Ficosa.
R&D Manager at FTE Maximal.
R&D Manager at SANYO.
Master in Project Management.
BSc in Telecom. Engineering.
+20 years of experience in strategic R&D positions managing the development of successful products and creating R&D teams from scratch to +120 people.